How quickly will I lose weight on semaglutide?

Average weight loss in the STEP 1 trial was around 15% of body weight over 68 weeks at the 2.4mg weekly dose, rising to approximately 20.7% at the newer 7.2mg maintenance dose over 72 weeks.
The titration schedule matters: doses increase gradually from 0.25mg, typically every four weeks, so results build rather than arriving all at once.
Most people notice reduced appetite within the first couple of weeks; visible weight changes usually follow over months, not days.
Individual factors (starting BMI, adherence to lifestyle changes, and how well you tolerate dose increases) shape how quickly results appear.

Most people taking semaglutide for weight loss notice meaningful changes within the first four to eight weeks, with the clearest results emerging after three to six months as the dose increases. Clinical trials show an average of around 15% body weight reduction over 68 weeks at the 2.4mg maintenance dose — though individual results depend on your starting weight, dose, diet, activity and how your body responds. These are prescription-only medicines: a prescriber assesses whether treatment is appropriate for you before anything is dispensed.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence and real-world timelines actually show

Step 1: The first four weeks — settling in, not yet transforming

Semaglutide treatment begins at 0.25mg weekly, a starting dose designed to let your body adjust rather than produce immediate weight loss. Many people notice a quieter appetite (fewer urges to snack, smaller portions feeling satisfying) within the first one to two weeks. The scale, though, tends to move slowly at this stage. If you step on it every morning expecting dramatic numbers, you'll likely feel underwhelmed. That's normal. The titration schedule exists precisely because jumping straight to a therapeutic dose causes more nausea, not faster results.

Gastrointestinal side effects (nausea, mild stomach discomfort, loose stools) are most common in these early weeks and usually settle as your body adapts. The NHS semaglutide medicines page has a full side-effect profile worth reading before you start. Most people lose a modest amount in the first month; 1–3kg is a reasonable expectation, not a ceiling.

Use this phase to establish the habits that sustain the results: adequate protein at each meal, steady hydration, and some form of movement you'll actually keep up. What happens in week one is far less important than what happens in month six.

Step 2: Months two to six, where the real momentum builds

As doses increase through 0.5mg, 1mg and eventually 1.7mg, the appetite-suppressing effect strengthens. This is when most people begin to see consistent weekly reductions on the scale. The pace varies: some people lose steadily through this window; others find weight loss slows temporarily around the three-month mark before picking up again when the next dose step is reached.

The STEP 1 trial, published in the New England Journal of Medicine, randomised 1,961 adults with obesity over 68 weeks; at 2.4mg, average weight reduction was around 15%, roughly 15kg for someone starting at 100kg. About a third of participants lost 20% or more. Those figures reflect once-weekly injections alongside a reduced-calorie diet and increased activity, which the trial protocol required.

Wondering how quickly Wegovy will work for you and what to expect in the early weeks? The pattern holds: gradual dose escalation, appetite reduction, then cumulative loss rather than a sharp early drop. Consistency matters more than speed at this stage.

Step 3: Maintenance and longer-term results

At the 2.4mg maintenance dose, the rate of weight loss typically slows but continues for several more months. For many people, the greatest total loss occurs between months six and twelve. After that, weight tends to plateau, a sign the medicine is doing its job of finding a new equilibrium, not a sign that it has stopped working.

The MHRA approved a higher 7.2mg maintenance dose in early 2026, with trial data reporting around 20.7% average weight loss over 72 weeks, approaching the results seen with tirzepatide in head-to-head comparisons. Whether that higher dose is appropriate depends on clinical assessment and individual response; your prescriber reviews your progress before any increase.

If you're also weighing up what Wegovy costs at different doses, it's worth knowing that treatment timelines and dose levels affect the overall investment. Our detailed breakdown of how quickly you lose weight on Wegovy covers the full picture of what to expect at each stage, including how the dose you eventually reach shapes your overall results, something also explored in our guide to how long semaglutide takes to produce meaningful loss.

What affects your individual pace of weight loss?

The trial averages are useful anchors, but they're averages. Several things shape how quickly you personally lose weight on semaglutide. Starting BMI plays a role: people with higher baseline weights often see larger absolute losses even when the percentage is similar. Adherence to the dose schedule matters too, missing injections, or staying on a lower dose longer than clinically advised, slows progress.

Diet and activity remain relevant. Semaglutide reduces appetite and slows gastric emptying, but it doesn't override energy balance entirely. People who pair treatment with higher protein intake and regular movement tend to preserve more muscle while losing fat, which affects both body composition and the number on the scale. If you're curious about how quickly semaglutides work across the broader class of medicines, there is genuine biological variation in how people respond to GLP-1 medicines; some experience marked appetite suppression from the first dose, others find the effect builds more slowly.

Our clinical team reviews every patient's progress before each repeat, partly to check for side effects, partly to consider whether a dose increase is appropriate. That ongoing clinical relationship is one of the more practically important parts of a supervised treatment programme, even when things are going well. If you'd like to understand when semaglutide starts to have a noticeable effect, that timeline sits slightly earlier than measurable weight loss, appetite changes often arrive first.

If you're thinking about starting treatment, a free consultation with our prescribers is the first step, no commitment, no waiting list.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions